Recent advances in therapeutic strategies for triple-negative breast cancer

Recent advances in therapeutic strategies for triple-negative breast cancer

Abstract Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer (BC) with a poor prognosis. Current treatment options are limited to surgery, adjuvant chemotherapy and radiotherapy; however, a proportion of patients have missed the surgical window at the time of diagnosi...

Full description

Bibliographic Details
Main Authors: Yun Li, Huajun Zhang, Yulia Merkher, Lin Chen, Na Liu, Sergey Leonov, Yongheng Chen
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Journal of Hematology & Oncology
Subjects:
Triple-negative breast cancer
Targeted therapy
Immunotherapy
Combination therapy
Online Access:https://doi.org/10.1186/s13045-022-01341-0

Internet

https://doi.org/10.1186/s13045-022-01341-0

Similar Items